22 min listen
The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Shannon Westin
The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Shannon Westin
ratings:
Length:
66 minutes
Released:
Jan 19, 2021
Format:
Podcast episode
Description
Dr Shannon Westin from the MD Anderson Cancer Center in Houston, Texas, discusses the role of PARP inhibition in the management of ovarian cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayASCOOvarian20)
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayASCOOvarian20)
Released:
Jan 19, 2021
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love